CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era

Bone Marrow Transplant. 2022 Nov;57(11):1740-1742. doi: 10.1038/s41409-022-01783-7. Epub 2022 Sep 8.

John L Vaughn¹, Samantha Brown², Esperanza B Papadopoulos^{1

3}, Ann A Jakubowski^{1

3}, Roni Tamari^{1

3}, Sergio A Giralt^{1

3}, Doris M Ponce^{1

3}, Christina Cho^{1

3}, Miguel-Angel Perales^{1

3}, Brian C Shaffer^{1

3}, Boglarka Gyurkocza^{4

5}

¹ Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
⁴ Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. gyurkocb@mskcc.org.
⁵ Department of Medicine, Weill Cornell Medical College, New York, NY, USA. gyurkocb@mskcc.org.

No abstract available

Publication types